To this end, we aimed to identify the role and source of P2RX7 in NASH, investigate the effects of P2RX7 inhibition on human liver cells and evaluate its potential as a therapeutic target for liver injury in non-human primates. The gene discussed is P2RX7; the disease is metabolic dysfunction-associated steatohepatitis.